Rishi R. Sekar, MD, MSc
Education
- BA, 2010, Emory College of Arts and Sciences Emory University, Atlanta, Georgia, Economics
- MD, 2016, Emory University School of Medicine Emory University, Atlanta, Georgia, Medicine
- M.Sc., 2023, Rackham Graduate School University of Michigan, Ann Arbor, Michigan, Health Services Research
- Residency, 2022, University of Washington, Seattle, Washington, Urology
- Fellowship, 2025, University of Michigan, Ann Arbor, Michigan, Urologic Oncology
Biography
Dr. Sekar completed his undergraduate training at Emory University where he earned a degree in Economics with concentrations in Health Economics and Behavioral Economics, graduating cum laude. He then worked as a health policy analyst focusing on national healthcare reform initiatives, specifically developing and studying new healthcare delivery models. He went on to earn his medical degree at Emory University, where he was inducted into the Alpha Omega Alpha honor society and graduated cum laude. He completed his residency in urologic surgery at the University of Washington, followed by a Society of Urologic Oncology fellowship at the University of Michigan. He has also received advanced training in health services and policy research through the National Clinician Scholars Program, formerly the Robert Wood Johnson Clinician Scholars Program. In 2025, Dr. Sekar joined the faculty at UCSF as an Assistant Professor of Urology.
Clinical Interests
Dr. Sekar specializes in the management of urologic cancers, including prostate, bladder, kidney, testis, adrenal, and urethral/penile cancers. He is experienced in both open and minimally invasive surgical techniques.
Research Interests
Dr. Sekar’s research focuses on improving cancer care delivery with a specific emphasis on addressing health disparities. He focuses on understanding social determinants of health and how they contribute to disparities across the healthcare continuum. Dr. Sekar also studies safety net hospitals, their evolving position in the United States healthcare system, and their role in delivering cancer care to vulnerable populations.